ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 31,...
Highlights Quarter two revenue of $2,063.5 million, an increase of 1.4% on quarter one 2026. Quarter two adjusted EBITDA of $327.2 million or 15.9%...
Barchart Research What to Expect from ICLR Earnings ICLR Generated July 28, 2026 Current Price $180.24 EPS Estimate $$2.26 Consensus Rating Moderate Buy Average Move 10.66% ICLR Reports Tomorrow After...
ICON plc (NASDAQ: ICLR) today announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle. The collaboration further advances ICON’s digital...
ICON plc , (NASDAQ: ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the second quarter 2026 after the market...
Barchart Research What to Expect from ICLR Earnings ICLR Generated July 21, 2026 Current Price $166.62 EPS Estimate $$2.26 Consensus Rating Moderate Buy Average Move 10.66% ICON's Lab Expansion Looks Confident...
Highlights Quarter one revenue of $2,034.0 million, an increase of 0.9% on quarter one 2025. Quarter one adjusted EBITDA of $317.7 million or 15.6%...
Barchart Research What to Expect from ICLR Earnings ICLR Generated June 22, 2026 Current Price $140.73 EPS Estimate $$2.18 Consensus Rating Moderate Buy Average Move 10.64% ICON's Backlog Momentum Could...